Literature DB >> 25374336

Acromegaly: assessing the disorder and navigating therapeutic options for treatment.

Shlomo Melmed1, David L Kleinberg2, Vivien Bonert3, Maria Fleseriu4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25374336     DOI: 10.4158/EP14430.RA

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  6 in total

1.  Predictive model of surgical remission in acromegaly: age, presurgical GH levels and Knosp grade as the best predictors of surgical remission.

Authors:  M Araujo-Castro; E Pascual-Corrales; V Martínez-Vaello; G Baonza Saiz; J Quiñones de Silva; A Acitores Cancela; A M García Cano; V Rodríguez Berrocal
Journal:  J Endocrinol Invest       Date:  2020-05-21       Impact factor: 4.256

2.  Daily life reflections of acromegaly guidelines.

Authors:  T Apaydin; H M Ozkaya; F E Keskin; O A Haliloglu; K Karababa; S Erdem; P Kadioglu
Journal:  J Endocrinol Invest       Date:  2016-10-20       Impact factor: 4.256

3.  Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly.

Authors:  Agnieszka Tomasik; Maria Stelmachowska-Banaś; Maria Maksymowicz; Izabella Czajka-Oraniec; Dorota Raczkiewicz; Grzegorz Zieliński; Jacek Kunicki; Wojciech Zgliczyński
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-16       Impact factor: 6.055

Review 4.  Current therapies and mortality in acromegaly.

Authors:  S Găloiu; C Poiană
Journal:  J Med Life       Date:  2015 Oct-Dec

Review 5.  Pasireotide: a novel treatment for patients with acromegaly.

Authors:  Daniel Cuevas-Ramos; Maria Fleseriu
Journal:  Drug Des Devel Ther       Date:  2016-01-11       Impact factor: 4.162

6.  Development of a novel patient-reported measure for acromegaly: the Acro-TSQ.

Authors:  Maria Fleseriu; Leon Fogelfeld; Murray B Gordon; Jill Sisco; Hilary H Colwell; William H Ludlam; Asi Haviv; Susan D Mathias
Journal:  Pituitary       Date:  2019-12       Impact factor: 4.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.